siRNA that inhibits er81 gene expression and its application in breast cancer cells
A breast cancer cell and gene expression technology, which is applied in the application field of inhibiting the expression level of ER81 gene in breast cancer cells, can solve the problems of insufficient understanding of the interaction, etc., and achieve an obvious inhibitory effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] Example 1: Construction of recombinant siRNA expression vector targeting human ER81 gene
[0049] 1. Synthesis of siDNA gene fragment targeting human ER81 gene
[0050] The human ER81 mRNA sequence was searched in the gene database GenBank on the NCBI website. There were 7 transcription mutants in the ER81 gene, and the gene accession numbers were: NM_004956, NM_001163147, NM_001163148, NM_001163149, NM_001163150, NM_001163151, NM_001163152. Find the common sequence of the 7 transcription mutants by sequence alignment and use their common sequence to search in Genscript's RNAi online design tool GenScriptsiRNATargetFinder (https: / / www.genscript.com / ssl-bin / app / rnai) Top scoring siRNA target sequences. Finally, the designed siRNA target sequences were compared in GenBank by BLAST to remove sequences that may hybridize with other irrelevant genes. Finally, target sequences at three positions in the upper, middle and lower reaches of the mRNA were selected to obtain the ...
Embodiment 2
[0073] Example 2: Inhibitory effect of recombinant siRNA expression vector on ER81 gene in breast cancer cell line MDA-MB-231 and its influence on cell biological characteristics
[0074] 1. The recombinant siRNA expression vector was stably transfected into MDA-MB-231 cells
[0075] Dilute 0.8 μg of each recombinant siRNA expression vector (pGenesil-ETV1A, pGenesil-ETV1B, pGenesil-ETV1C, pGenesil-NC ) and the original siRNA expression vector pGenesil-1, mix gently. Dilute 2 μl of Lipofectamine with 298 μl of OPTI-MEM low serum medium TM 2000 (purchased from Invitrogen), incubated at room temperature for 5 minutes. Diluted expression vector DNA and diluted Lipofectamine TM 2000 equal volumes were mixed and incubated at room temperature for 20 minutes after mixing. Take out the laid 24-well culture plate, discard the original culture medium, then add 600 μl of transfection mixture dropwise to each well, mix well and put the culture plate back into the incubator. After cult...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com